Glycogen storage disease type I screening: Difference between revisions
Jump to navigation
Jump to search
Irfan Dotani (talk | contribs) (Created page with "__NOTOC__ {{Glycogen storage disease type I}} {{CMG}}; {{AE}} {{PleaseHelp}} ==Overview== ==Screening== ==References== {{reflist|2}} Category:Gastroenterology Categ...") |
|||
Line 8: | Line 8: | ||
==Screening== | ==Screening== | ||
*Glycogen storage disease type 1 is an autosomal recessive disease. | |||
*Carrier screening of at-risk relatives may be done. | |||
*screening requires prior identification of G6PC or SLC37A4 pathogenic variants in the family. | |||
==References== | ==References== |
Revision as of 20:37, 20 November 2017
Glycogen storage disease type I Microchapters |
Differentiating Glycogen storage disease type I from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Glycogen storage disease type I screening On the Web |
American Roentgen Ray Society Images of Glycogen storage disease type I screening |
Directions to Hospitals Treating Glycogen storage disease type I |
Risk calculators and risk factors for Glycogen storage disease type I screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Screening
- Glycogen storage disease type 1 is an autosomal recessive disease.
- Carrier screening of at-risk relatives may be done.
- screening requires prior identification of G6PC or SLC37A4 pathogenic variants in the family.